Mike Graffeo 🇺🇸

CEO and co-founder at @FluidFormBio, #3Dbioprinting, #regenmed, #leadership, #technology @Cornell @HarvardHBS

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@DrPhiltill I hope that there’s never a reason to apologize for optimism and shooting for the stars. We need that as species. The balance is when to discard the old ways as antiquated versus when to learn from the old ways for the important signal. That takes courage, humility, leadership

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@DanielPink That’s a great story!

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@DrPhiltill I also agree it’s not a good reason to attempt to stop progress. And when you’re talking about “you might have cancer”, it needs to be thought through. “We’ll have plenty of data in a few years” is great, unless one of your loved ones is going through that scare

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@DrPhiltill sounds like we agree on the potential benefit. I think the interesting question is how much downside there will be before those changes are enacted to bend the curve. In this case, I can imagine millions of additional cancer workups, tons of cost, etc. not to be taken lightly.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@DrPhiltill @grok Phil, it’s the right direction to try to go. Most doctors I’ve worked with would also like to move in that direction. That said, it would require significant legal reform before a doc could do that and not worry about the risk.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@grok @DrPhiltill And in the case of the midjourney tech, a big portion of the value proposition is how easy it is to do more of it.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@grok @DrPhiltill Yes, @grok is correctly pointing out that the trajectory has always been new modality > spike in overdiagnosis > restriction in utilization.

“It will all work out in the long run” has meant it will be used less than we expected.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@stevemagness Underrated take! Once saw a guy at an Ironman finish line with all his gear spread out saying “everything for sale; I’m never doing that again!” I felt so bad for him. What a terrible way to spend your time

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@incinewsNE Check out the 1 degree outside live stream, they’re covering it right now

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@Lorrie57 Check out the 1 degree outside live stream, they’re covering it now

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@markames1969 Check out the 1 degree outside live stream, they’re talking about it now

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@ArtirKel Let’s assume all those treatments pan out (a big assumption). We still have an enormous issue with medication adherence. And there are no interventions being tested to change that dynamic. Unlikely to see CVD “gone” any time soon.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@Brady_H @maxlugavere Whatever excuse one needs to eat more peanut butter, just go for it

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@stevemagness This is my biggest frustration with every spin instructor I’ve ever heard. They’ll use terms like sprint, all-out, max effort, and have no idea how an actual athlete will respond. Drives me nuts

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@Brady_H The fact that Ben G is anywhere near a list of folks grounded in science is a joke

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@nxthompson That’s cold. And basically accurate.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@amankrai28 @tim_roozendaal @AK_El_Jefe Yes, you’re right, the two are not necessarily the same. FuelCell comes in wide widths, and is known for having a wide toe box.

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@RileyDaniel03 @GregABedard @jsgiii22661 True, but only 4 to 5 games back throughout May. Getting 10 games back this early is actually pretty hard

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@GregABedard @jsgiii22661 I think it’s 1997. C’s and B’s both missed the playoffs. Sox were 10 games out by May 14

[Mike Graffeo 🇺🇸 @michaelgraffeo]

@GregABedard @jsgiii22661 Isn’t it 2016 for a? Bruins missed the playoffs, c’s out in the first round. Sox were in first place then, so gotta go further back for b.